Dr Sameer Agarwal

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Identification of degradation impurity of TGR5 receptor agonist-ZY12201 by LC–MS technique during force degradation study
  SN Applied Sciences 2021 DOI: 10.1007/s42452-021-04660-y
  +Save
• Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor
  Bioorganic & Medicinal Chemistry Letters 2020 DOI: 10.1016/j.bmcl.2020.127571
  +Save
• Discovery of N-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome Inhibitors
  ACS Medicinal Chemistry Letters 2020 DOI: 10.1021/acsmedchemlett.9b00433
  +Save
• Development of Chromatographic Method for Determination of Impurities in Solid Dispersion of Dasatinib
  Brazilian Journal of Analytical Chemistry 2019 DOI: 10.30744/brjac.2179-3425.2018.5.21.19-29
  +Save
• Development and validation of residual solvent determination by headspace gas chromatography in Imatinib Mesylate API
  SN Applied Sciences 2019 DOI: 10.1007/s42452-019-0233-x
  +Save
• Novel 2-mercapto imidazole and triazole derivatives as potent TGR5 receptor agonists
  Medicine in Drug Discovery 2019 DOI: 10.1016/j.medidd.2019.100002
  +Save
• Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes
  Bioorganic & Medicinal Chemistry Letters 2018 DOI: 10.1016/j.bmcl.2018.04.011
  +Save